According to Goldstein Research, global substance abuse treatment market is expected to reach USD 4.68 billion by 2025, growing at a CAGR of 5.1% over the forecast period 2017-2025. The substance abuse treatment pipeline is led by cure for nicotine and alcohol addiction, with the 34 products in nicotine addiction bucket of treatment and 32 products for alcohol addiction under active development combining to produce over 50% of the total pipeline. Global substance abuse treatment market segmentation has been done on the basis of the type of substance abuse treatment and geography. Alcohol abuse treatment is the largest segment to contribute around 40% market share of overall substance abuse treatment market in 2017.

Global substance abuse treatment market is largely dominated by North America on the back of emerging product segments including cocaine and opioid addictions, with 26 and 21 pipeline drugs respectively. Further, the increasing drug-addicted population and government initiatives to control substance abuse such as in New Zealand, Iceland, Russia, Scotland, Brazil, Canada, Afghanistan, UK, Mexico, Australia, El Salvador, Iran, Netherlands, Slovakia tend to be the opportunistic market in near future.

Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/substance-abuse-treatment-market-analysis

Market Segmentation

On the basis of our in-depth analysis, Global Substance Abuse Treatment Market can be segmented as follows:

By Type of Substance Abuse Treatment

o Alcohol abuse treatment
o Nicotine abuse treatment
o Drug abuse treatment

By Region

o North America (US, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
o Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}

Browse Full Report: https://www.goldsteinresearch.com/report/substance-abuse-treatment-market-analysis

“Global Substance Abuse Treatment Market Outlook 2025” contains a detailed overview of the global substance abuse treatment market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by type of substance abuse treatment and geography.

Further, for the in-depth analysis, Global Substance Abuse Treatment Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such as Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Mylan Laboratories, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharma, and Teva Pharmaceutical, etc.

The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services, and industries catered, financial analysis of the company and recent developments.

Overall, the report represents the global substance abuse treatment market trends along with the market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.

Our analysts working on healthcare market research reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Contact for more Info:
Steve Blade
(Global Sales Head)
USA: + 1-646-568-7747
Canada: 1-437-886-1181
UK: +44-203-318-6627
[email protected]
www.goldsteinresearch.com

Browse Similar Report: United States Substance Abuse Treatment Market